USU Once Again Awarded Platinum for Annual Report
EQS-News: USU Software AG AG
/ Key word(s): Miscellaneous
USU Once Again Awarded Platinum for Annual Report
19.09.2024 / 14:11 CET/CEST
The issuer is solely responsible for the content of this announcement.
Möglingen,...
|
CTBUH 2024 International Conference in London Spotlights Thailand’s Legendary Landmark: Dusit Central Park
EQS Newswire / 19/09/2024 / 12:15 CET/CEST
LONDON, UNITED KINGDOM - Media OutReach Newswire - 19 September 2024 - Dusit Central Park, a complete mixed-use development in Bangkok's Super Core CBD, the newest project among Thailand's Top 5 TallestBuildings,...
|
Further Delay in Annual Financial Statements 2023
EQS-News: LIBERO football finance AG
/ Key word(s): Annual Report
Further Delay in Annual Financial Statements 2023
19.09.2024 / 12:06 CET/CEST
The issuer is solely responsible for the content of this announcement.
Frankfurt...
|
tick Trading Software AG now offers the connection to Spectrum Markets
EQS-News: tick Trading Software AG AG
/ Key word(s): Product Launch
tick Trading Software AG AG now offers the connection to Spectrum Markets
19.09.2024 / 11:30 CET/CEST
The issuer is solely responsible for the content...
|
Lehman Brothers UK Capital Funding V LP: Notice to the Holders of the Preferred Securities
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: USD 500,000,000 FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP V ECAPS") ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING V LP ("LP V") ISIN: XS0301813522 LIQUIDATION...
|
Lehman Brothers UK Capital Funding LP: Notice to the Holders of the Preferred Securities
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 225,000,000 FIXED RATE TO CMS-LINKED GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP I Securities") ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING LP ("LP...
|
Filevine’s LEX Summit 2024: A Landmark Event for the Legal Industry
Jake Gyllenhaal, Camille Vasquez, The Innocence Project, and Nelly joined a powerhouse lineup of industry thought leaders at Filevine’s premier legal conference. Salt Lake City, UT, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Filevine, leading provider of legal technology,...
|
NobleAI Recognized in Gartner’s Market Guide for Materials Informatics Solutions
Report Highlights Company’s Strength and Unique Offering in Emerging AI for Science Sector SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NobleAI, a pioneer in Science-Based AI solutions for Materials Informatics, has been named in Gartner’s recently released...
|
32BJ Labor Industry Cooperation Fund Releases Interactive Tools to Help Employers and Unions Achieve Lower Hospital Prices
Healthcare Savings Calculator and Healthcare Administrator “Contract-first” Template available at no cost to purchasers NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Hospital prices are the core driver of high and rising healthcare costs and significant savings...
|
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
Company actively advancing lead ophthalmology drug candidate to first Investigational New Drug (IND) filing REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics...
|
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ablation...
|
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus...
|
Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction feature The launch will expectedly improve Evaxion’s ability to fast and effectively discover AI-derived...
|
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), taking...
|
Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH
ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by MRI-PDFF Placebo-adjusted median relative reductions in liver fat were up to 46.2% with a clear dose response ALG-055009 was well-tolerated...
|